Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: BioVaxys Technology Corp

Announced today that its clinical study collaborator Hospices Civils de Lyon in France has surgically ...

BIOV.CN : 0.100 (-4.76%)
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its clinical study collaborator...

BIOV.CN : 0.100 (-4.76%)
BVAXF : 0.0850 (+6.25%)
Stocks in play: BioVaxys Technology Corp

Announced today that its Lyon, France-based bioproduction partner, BioElpida, has completed the creation ...

BIOV.CN : 0.100 (-4.76%)
Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its Lyon, France-based bioproduction...

BIOV.CN : 0.100 (-4.76%)
BVAXF : 0.0850 (+6.25%)
Stocks in play: BioVaxys Technology Corp

Announced today that The Ohio State University, its research collaborator that is jointly evaluating ...

BIOV.CN : 0.100 (-4.76%)
BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that The Ohio State University ("Ohio...

BIOV.CN : 0.100 (-4.76%)
BVAXF : 0.0850 (+6.25%)
Stocks in play: BioVaxys Technology Corp

Announced today that Hospices Civils de Lyon, France has agreed to serve as a clinical study site for ...

BIOV.CN : 0.100 (-4.76%)
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression

Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – Companies in the Ovarian Cancer market are spending a lot of R&D on vaccine development, therapies and studies. For the past...

BIOV.CN : 0.100 (-4.76%)
BVAXF : 0.0850 (+6.25%)
CLSN : 1.9300 (+4.89%)
IMGN : 4.61 (+2.44%)
ZNTL : 29.03 (+3.31%)
BMY : 76.84 (-0.21%)
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement

Vancouver, BC –  May 18, 2022 — BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or “Company”), announced today that Hospices Civils de Lyon, France (“HCL”)...

BVAXF : 0.0850 (+6.25%)
BIOV.CN : 0.100 (-4.76%)
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV; FRA: 5LB; OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that Hospices Civils de Lyon, France ("HCL")...

BIOV.CN : 0.100 (-4.76%)
BVAXF : 0.0850 (+6.25%)

Barchart Exclusives

2 BDC Stocks Yield Over 10% With Excellent Covered Call Plays
These 2 business development companies (BDCs) yield over 10%, even before some extra quarterly dividends they have been issuing. In addition, they off excellent covered call opportunities for investors. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar